Roche, Lilly’s blood test for Alzheimer’s diagnosis gets US approval
PositiveFinancial Markets

Roche and Lilly have received US approval for their innovative blood test designed to diagnose Alzheimer's disease. This breakthrough is significant as it offers a less invasive and more accessible method for early detection of Alzheimer's, potentially improving patient outcomes and treatment options. With Alzheimer's affecting millions, this advancement could change the landscape of how we approach this challenging condition.
— Curated by the World Pulse Now AI Editorial System